SCHEMBL8162269

SCHEMBL8162269

COc1cc(O)cc(O)c1OC

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.77
▸ MAPT P10636 1/20 0.77
▸ TDP1 Q9NUW8 1/20 0.73
▸ TPMT P51580 1/20 0.57
▸ MAOB P27338 1/20 0.52
▸ TUBB1 Q9H4B7 3/20 0.48
▸ TUBB4A P04350 2/20 0.48
▸ TUBB P07437 2/20 0.48
▸ TUBA3C P0DPH7 2/20 0.48
▸ TUBA1B P68363 2/20 0.48
▸ TUBA4A P68366 2/20 0.48
▸ TUBB4B P68371 2/20 0.48
▸ TUBB3 Q13509 2/20 0.48
▸ TUBB2A Q13885 2/20 0.48
▸ TUBB8 Q3ZCM7 2/20 0.48
▸ TUBA3E Q6PEY2 2/20 0.48
▸ TUBA1A Q71U36 2/20 0.48
▸ TUBA1C Q9BQE3 2/20 0.48
▸ TUBB6 Q9BUF5 2/20 0.48
▸ TUBB2B Q9BVA1 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Antiarol SCHEMBL210578 0.87 CYP3A4 (1.00) CYP3A4MAPTTDP1TPMTMAOB
Antiarol SCHEMBL27791677 0.85 CYP3A4 (0.95) CYP3A4MAPTTDP1TPMTMAOB
Iretol SCHEMBL3190103 0.85 TDP1 (1.00) CYP3A4MAPTTDP1TPMTMAOB
SCHEMBL1402215 0.84 CYP3A4 (0.60) CYP3A4MAPTTDP1TPMTMAOB
SCHEMBL67495 0.80 PTGS2 (0.64) CYP3A4MAPTTDP1MAOBPTGS2
SCHEMBL29421987 0.79 CYP3A4 (0.74) CYP3A4MAPTTDP1TPMTMAOB
SCHEMBL17265618 0.79 CYP3A4 (0.74) CYP3A4MAPTTDP1TPMTMAOB
SCHEMBL29421895 0.79 ACHE (0.70) CYP3A4MAPTTDP1TPMTTUBB1
SCHEMBL1427958 0.79 ACHE (0.70) CYP3A4MAPTTDP1TPMTTUBB1
SCHEMBL9768502 0.78 CYP3A4 (0.58) CYP3A4MAPTTDP1TPMTTUBB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2594563-B1 2-acylaminopropanol-type glucosylceramide synthase inhibitors GENZYME CORP (US) 2018-07-18 — — EP disclosed
EP-0773919-B1 METHOD FOR PREPARING 3-CARBOXY-4-HYDROXYBENZALDEHYDES AND DERIVATIVES THEREOF RHODIA CHIMIE SA (FR) 2000-09-20 — — EP disclosed
EP-0773919-A1 METHOD FOR PREPARING 3-CARBOXY-4-HYDROXYBENZALDEHYDES AND DERIVATIVES THEREOF RHONE-POULENC CHIMIE (FR) 1997-05-21 — — EP disclosed
WO-1996037454-A1 METHOD FOR PREPARING 3-CARBOXY-4-HYDROXYBENZALDEHYDES AND DERIVATIVES THEREOF RHONE-POULENC CHIMIE (FR) 1996-11-28 — — WO disclosed
US-4435601-A OXIDATION WITH HYDROGEN PEROXIDE IN ALKALI OR ALKALINE METAL BASE RHONE-POULENC INDUSTRIES (FR) 1984-03-06 — — US disclosed
Send feedback